Alteration of the immune environment in bone marrow from children with recurrent B cell precursor acute lymphoblastic leukemia.


Journal

Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 06 10 2021
received: 04 05 2021
accepted: 25 10 2021
pubmed: 31 10 2021
medline: 13 1 2022
entrez: 30 10 2021
Statut: ppublish

Résumé

Due to the considerable success of cancer immunotherapy for leukemia, the tumor immune environment has become a focus of intense research; however, there are few reports on the dynamics of the tumor immune environment in leukemia. Here, we analyzed the tumor immune environment in pediatric B cell precursor acute lymphoblastic leukemia by analyzing serial bone marrow samples from nine patients with primary and recurrent disease by mass cytometry using 39 immunophenotype markers, and transcriptome analysis. High-dimensional single-cell mass cytometry analysis elucidated a dynamic shift of T cells from naïve to effector subsets, and clarified that, during relapse, the tumor immune environment comprised a T helper 1-polarized immune profile, together with an increased number of effector regulatory T cells. These results were confirmed in a validation cohort using conventional flow cytometry. Furthermore, RNA transcriptome analysis identified the upregulation of immune-related pathways in B cell precursor acute lymphoblastic leukemia cells during relapse, suggesting interaction with the surrounding environment. In conclusion, a tumor immune environment characterized by a T helper 1-polarized immune profile, with an increased number of effector regulatory T cells, could contribute to the pathophysiology of recurrent B cell precursor acute lymphoblastic leukemia. This information could contribute to the development of effective immunotherapeutic approaches against B cell precursor acute lymphoblastic leukemia relapse.

Identifiants

pubmed: 34716967
doi: 10.1111/cas.15186
pmc: PMC8748249
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-52

Subventions

Organisme : AMED
ID : JP21ck0106531
Organisme : Bristol Myers Squibb
Organisme : Mochida Memorial Foundation for Medical and Pharmaceutical Research
Organisme : Mother and Child Health Foundation

Informations de copyright

© 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

Références

Hematology. 2015 Oct;20(9):523-9
pubmed: 26119924
Cell Mol Immunol. 2018 Apr;15(4):299-311
pubmed: 29082918
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):565-9
pubmed: 25696912
Immunity. 2012 Nov 16;37(5):785-99
pubmed: 23123060
F1000Res. 2017 May 26;6:748
pubmed: 28663787
Semin Immunopathol. 2012 Jan;34(1):133-49
pubmed: 21971685
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Front Oncol. 2019 May 17;9:415
pubmed: 31165047
Cancer Discov. 2018 Sep;8(9):1066-1068
pubmed: 30181171
Blood. 2010 Dec 2;116(23):4874-84
pubmed: 20699438
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
J Hematol Oncol. 2015 Oct 08;8:111
pubmed: 26449653
J Pediatr Hematol Oncol. 2015 Oct;37(7):498-501
pubmed: 26376233
N Engl J Med. 2017 Mar 2;376(9):836-847
pubmed: 28249141
Int Immunol. 2016 Apr;28(4):163-71
pubmed: 26874355
Oncogene. 2019 Mar;38(13):2420-2431
pubmed: 30532071
Nat Biotechnol. 2013 Jun;31(6):545-52
pubmed: 23685480
Cancer Sci. 2020 Jul;111(7):2223-2233
pubmed: 32324315
Cell Res. 2017 Jan;27(1):109-118
pubmed: 27995907
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cancer Sci. 2019 Jul;110(7):2080-2089
pubmed: 31102428
J Exp Med. 2009 Jan 16;206(1):69-78
pubmed: 19139170
Front Immunol. 2016 May 17;7:184
pubmed: 27242791
Oncol Lett. 2012 Feb;3(2):421-424
pubmed: 22740924
Leukemia. 2020 Oct;34(10):2607-2620
pubmed: 32203137
Nat Commun. 2011;2:240
pubmed: 21407206
Cell. 2008 May 30;133(5):775-87
pubmed: 18510923
Cancer Cell. 2020 Sep 14;38(3):380-399.e13
pubmed: 32649887
Oncol Rep. 2016 May;35(5):2699-706
pubmed: 26985678
Front Immunol. 2019 Feb 27;10:333
pubmed: 30873179
Exp Cell Res. 2011 Mar 10;317(5):620-31
pubmed: 21376175
Commun Biol. 2019 May 14;2:183
pubmed: 31098416
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Int Immunol. 2000 Feb;12(2):151-60
pubmed: 10653850
Leukemia. 2019 Jul;33(7):1570-1582
pubmed: 30635636
Sci Rep. 2018 Jul 17;8(1):10770
pubmed: 30018331
J Pediatr Hematol Oncol. 2013 Oct;35(7):509-13
pubmed: 23887024
J Immunol. 2000 Sep 15;165(6):3136-44
pubmed: 10975827
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
Oncotarget. 2016 Nov 22;7(47):76902-76919
pubmed: 27708227
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Immunology. 2014 May;142(1):124-39
pubmed: 24354800
J Clin Invest. 1997 Nov 15;100(10):2552-61
pubmed: 9366570
Curr Opin Immunol. 2014 Apr;27:1-7
pubmed: 24413387
Cancer Sci. 2022 Jan;113(1):41-52
pubmed: 34716967
Immunopharmacol Immunotoxicol. 2018 Apr;40(2):158-167
pubmed: 29388481
Br J Cancer. 2015 Apr 28;112(9):1421-7
pubmed: 25856776
Cytometry A. 2012 Sep;81(9):727-31
pubmed: 22887982
Immunity. 2019 Feb 19;50(2):302-316
pubmed: 30784578
Pediatr Infect Dis J. 2014 Sep;33(9):e219-25
pubmed: 24618935
Biomed Res Int. 2015;2015:386165
pubmed: 26090405
Lancet. 2020 Apr 4;395(10230):1146-1162
pubmed: 32247396
Cytokine. 2015 Feb;71(2):302-11
pubmed: 25497737
Immunity. 2009 Jun 19;30(6):899-911
pubmed: 19464196
Cell Syst. 2018 May 23;6(5):612-620.e5
pubmed: 29605184

Auteurs

Takashi Mikami (T)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Itaru Kato (I)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

James Badger Wing (JB)

Laboratory of Human Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Hiroo Ueno (H)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Keiji Tasaka (K)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Kuniaki Tanaka (K)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hirohito Kubota (H)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Satoshi Saida (S)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Katsutsugu Umeda (K)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hidefumi Hiramatsu (H)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Tomoya Isobe (T)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Mitsuteru Hiwatari (M)

Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Ai Okada (A)

Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.

Kenichi Chiba (K)

Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.

Yuichi Shiraishi (Y)

Division of Genome Analysis Platform Development, National Cancer Center Research Institute, Tokyo, Japan.

Hiroko Tanaka (H)

M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.

Satoru Miyano (S)

M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan.

Yuki Arakawa (Y)

Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.

Koichi Oshima (K)

Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.

Katsuyoshi Koh (K)

Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.

Souichi Adachi (S)

Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Keiko Iwaisako (K)

Department of Medical Life Systems, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Molecular Oncology, Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto, Japan.
Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.

Shimon Sakaguchi (S)

Laboratory of Experimental Immunology, Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Junko Takita (J)

Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH